Login / Signup

Pneumonic-type lung adenocarcinoma with KRAS G12V mutation and sustained response to Afatinib.

Jie ZhaoJiachen XuTian QiuJie WangZhijie Wang
Published in: Pneumonia (Nathan Qld.) (2024)
Our case highlights the typical and dynamic changes in imaging features of P-ADC and provides an indicative treatment strategy for KRAS G12V-mutated lung adenocarcinoma.
Keyphrases
  • wild type
  • high resolution
  • advanced non small cell lung cancer
  • magnetic resonance imaging
  • epidermal growth factor receptor